GSTM1 and anemia: As indicated in Table 2, ULs patients had increased clinical evidence of anaemia (defined as Hb < 12 g/dL; OR 2.99, p < 0.02), menometrorrhagia (OR 5.70, p < 0.001) and headaches (OR 3.07, p < 0.02).